# Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19

> **NCT04928495** · PHASE3 · UNKNOWN · sponsor: **Universidade Federal do Ceara** · enrollment: 219 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Vitamin C
- **DRUG:** N-acetylcysteine (NAC)
- **DRUG:** NAC + Bromhexine (BMX)

## Key facts

- **NCT ID:** NCT04928495
- **Lead sponsor:** Universidade Federal do Ceara
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-15
- **Primary completion:** 2022-04-09
- **Final completion:** 2022-06-09
- **Target enrollment:** 219 (ESTIMATED)
- **Last updated:** 2021-06-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04928495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04928495, "Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04928495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*